Metabolic Stress Signaling

代谢应激信号

基本信息

  • 批准号:
    10263263
  • 负责人:
  • 金额:
    $ 52.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-04-01 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Human obesity represents a serious world-wide health problem. One consequence of obesity is the development of metabolic syndrome, characterized by insulin resistance and hyperglycemia, that can lead to b-cell dysfunction and type 2 diabetes. It is therefore important that we gain an understanding of the physiology and pathophysiology of the development of obesity because this knowledge represents a basis for the design of potential therapeutic interventions. Recent studies have identified the cJun NH2-terminal kinase (JNK) signal transduction pathway as a mediator of metabolic stress responses. Feeding a high fat diet (HFD) causes increased JNK activity and promotes both obesity and insulin resistance. Studies using tissue-specific knockout mice demonstrate a central role for JNK in the regulation of energy expenditure and the development of obesity. In contrast, JNK in peripheral tissues can cause insulin resistance without changes in obesity. The mechanism that accounts for JNK-dependent insulin resistance caused by feeding a HFD has not been defined. This research program is focused on the metabolic function of hepatic JNK signaling. During the initial period of research support, we identified the PPARa pathway as a major target of hepatic JNK signaling that contributes to HFD-induced insulin resistance. We demonstrated that JNK activation caused by feeding a HFD potently suppresses PPARa activity. A key target of PPARa -mediated hepatic gene expression is the hepatokine fibroblast growth factor 21 (FGF21). Consequently, disruption of JNK signaling in the liver causes increased hepatic PPARa activity, increased amounts of FGF21 circulating in the blood, and improved glycemia in HFD-fed mice. Disruption of hepatic Fgf21 expression prevents the effects of JNK deficiency to cause improved glycemia. The PPARa/FGF21 axis therefore represents a major target of hepatic JNK signaling that promotes systemic insulin sensitivity. The overall goal of this research program is to identify mechanisms of hepatic JNK signaling that contribute to the regulation of insulin sensitivity. Our analysis establishes a key role for hepatic PPARa. However, the molecular target(s) that mediate the effects of JNK on PPARa have not been established. The identification of molecular mechanism is the focus of this renewal application. Achievement of the goals of this proposal will increase understanding of the molecular response to obesity. We anticipate that the successful completion of this research program will lead to the identification of new mechanisms that contribute to the obesity response. This knowledge may represent a basis for the design of novel therapeutic strategies for the treatment of metabolic syndrome and type 2 diabetes.
人类肥胖是一个严重的世界性健康问题。肥胖的一个后果是 以胰岛素抵抗和高血糖为特征的代谢综合征的发展,可导致b细胞功能障碍和2型糖尿病。因此,我们必须了解肥胖发生的生理学和病理生理学,因为这些知识是设计潜在的治疗干预措施的基础。最近的研究发现,cJun NH2末端激酶(JNK)信号转导通路是代谢应激反应的中介。喂食高脂肪饮食(HFD)会导致JNK活性增加,并促进肥胖和胰岛素抵抗。使用组织特异性基因敲除小鼠的研究表明,JNK在调节能量消耗和肥胖症的发展中发挥着核心作用。相比之下,外周组织中的JNK可以在不改变肥胖的情况下导致胰岛素抵抗。喂养高脂饲料引起的JNK依赖型胰岛素抵抗的机制尚未明确。本研究的重点是肝脏JNK信号的代谢功能。在研究支持的最初阶段,我们发现PPARa通路是肝脏JNK信号转导的一个主要靶点,参与了HFD诱导的胰岛素抵抗。我们证明了由饲喂HFD引起的JNK激活有效地抑制了PPARa活性。PPARa介导的肝脏基因表达的一个关键靶点是肝细胞因子成纤维细胞生长因子21(FGF21)。因此,肝脏中JNK信号的中断导致肝脏PPARa活性增加,血液中循环的FGF21数量增加,并改善高脂饲料喂养的小鼠的血糖。阻断肝脏FGF21的表达可阻止JNK缺乏症引起的血糖改善。因此,PPARa/FGF21轴是肝脏JNK信号的主要靶点,促进全身性胰岛素敏感性。该研究计划的总体目标是确定肝脏JNK信号调节胰岛素敏感性的机制。我们的分析确定了肝脏PPARa的关键作用。然而,介导JNK对PPARa影响的分子靶点(S)尚未建立。分子机理的识别是这一更新应用的重点。这项提案的目标的实现将增加对肥胖分子反应的理解。我们预计,这项研究计划的成功完成将导致识别有助于肥胖反应的新机制。这些知识可能是设计治疗代谢综合征和2型糖尿病的新治疗策略的基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Roger J Davis其他文献

Keep the 'phospho' on MAPK, be happy
让 MAPK 上保留“磷酸”,开心点。
  • DOI:
    10.1038/nm1110-1187
  • 发表时间:
    2010-11-04
  • 期刊:
  • 影响因子:
    50.000
  • 作者:
    Schahram Akbarian;Roger J Davis
  • 通讯作者:
    Roger J Davis
Signaling and Cell Cycle Regulation During Liver Development in the Rat• 269
大鼠肝脏发育过程中的信号传导和细胞周期调控•269
  • DOI:
    10.1203/00006450-199804001-00290
  • 发表时间:
    1998-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Philip A Gruppuso;Michael Awad;Joan M Boylan;Herve Enslen;Roger J Davis
  • 通讯作者:
    Roger J Davis

Roger J Davis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Roger J Davis', 18)}}的其他基金

Promotion of fatty liver disease by the ASK1 pathway
ASK1 通路促进脂肪肝疾病
  • 批准号:
    10224186
  • 财政年份:
    2019
  • 资助金额:
    $ 52.78万
  • 项目类别:
Promotion of fatty liver disease by the ASK1 pathway
ASK1 通路促进脂肪肝疾病
  • 批准号:
    10021651
  • 财政年份:
    2019
  • 资助金额:
    $ 52.78万
  • 项目类别:
Adipose Tissue Metabolic Stress Responses
脂肪组织代谢应激反应
  • 批准号:
    9401372
  • 财政年份:
    2017
  • 资助金额:
    $ 52.78万
  • 项目类别:
Adipose Tissue Metabolic Stress Responses
脂肪组织代谢应激反应
  • 批准号:
    10651878
  • 财政年份:
    2017
  • 资助金额:
    $ 52.78万
  • 项目类别:
Adipose Tissue Metabolic Stress Responses
脂肪组织代谢应激反应
  • 批准号:
    10516801
  • 财政年份:
    2017
  • 资助金额:
    $ 52.78万
  • 项目类别:
Metabolic stress signaling
代谢应激信号
  • 批准号:
    9128103
  • 财政年份:
    2016
  • 资助金额:
    $ 52.78万
  • 项目类别:
Metabolic Stress Signaling
代谢应激信号
  • 批准号:
    10656434
  • 财政年份:
    2016
  • 资助金额:
    $ 52.78万
  • 项目类别:
Metabolic Stress Signaling
代谢应激信号
  • 批准号:
    10119846
  • 财政年份:
    2016
  • 资助金额:
    $ 52.78万
  • 项目类别:
Metabolic Stress Signaling
代谢应激信号
  • 批准号:
    10437020
  • 财政年份:
    2016
  • 资助金额:
    $ 52.78万
  • 项目类别:
Systems Biology of Insulin Resistance
胰岛素抵抗的系统生物学
  • 批准号:
    8053081
  • 财政年份:
    2011
  • 资助金额:
    $ 52.78万
  • 项目类别:

相似海外基金

Characterizing RNA regulation in B lymphocytes
B 淋巴细胞中 RNA 调控的特征
  • 批准号:
    502601
  • 财政年份:
    2024
  • 资助金额:
    $ 52.78万
  • 项目类别:
B Lymphocytes in Autoimmune Disease
自身免疫性疾病中的 B 淋巴细胞
  • 批准号:
    10370125
  • 财政年份:
    2022
  • 资助金额:
    $ 52.78万
  • 项目类别:
Characterization of Streptococcus suis interactions with B lymphocytes
猪链球菌与 B 淋巴细胞相互作用的表征
  • 批准号:
    573206-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 52.78万
  • 项目类别:
    University Undergraduate Student Research Awards
Altered B lymphocytes Due to Tungstate Exposure
钨酸盐暴露导致 B 淋巴细胞发生改变
  • 批准号:
    RGPIN-2020-05899
  • 财政年份:
    2022
  • 资助金额:
    $ 52.78万
  • 项目类别:
    Discovery Grants Program - Individual
The regulation of signaling and cytoskeletal rearrangements in B-lymphocytes
B 淋巴细胞信号传导和细胞骨架重排的调节
  • 批准号:
    RGPIN-2019-04911
  • 财政年份:
    2022
  • 资助金额:
    $ 52.78万
  • 项目类别:
    Discovery Grants Program - Individual
Myocardial-associated B lymphocytes and inflammatory injury
心肌相关B淋巴细胞与炎症损伤
  • 批准号:
    10543825
  • 财政年份:
    2022
  • 资助金额:
    $ 52.78万
  • 项目类别:
Myocardial-associated B lymphocytes and inflammatory injury
心肌相关B淋巴细胞与炎症损伤
  • 批准号:
    10339541
  • 财政年份:
    2022
  • 资助金额:
    $ 52.78万
  • 项目类别:
Exploring RNA helicase DDX the role of the1 at the crossroad of DNA repair processes in B lymphocytes
探索 RNA 解旋酶 DDX 在 B 淋巴细胞 DNA 修复过程十字路口的作用
  • 批准号:
    BB/X511560/1
  • 财政年份:
    2022
  • 资助金额:
    $ 52.78万
  • 项目类别:
    Training Grant
Role and regulation of extracellular vesicles generated in response to stimulation of CD24 on B lymphocytes
B 淋巴细胞上 CD24 刺激产生的细胞外囊泡的作用和调节
  • 批准号:
    RGPIN-2022-03800
  • 财政年份:
    2022
  • 资助金额:
    $ 52.78万
  • 项目类别:
    Discovery Grants Program - Individual
B Lymphocytes in Autoimmune Disease
自身免疫性疾病中的 B 淋巴细胞
  • 批准号:
    10640819
  • 财政年份:
    2022
  • 资助金额:
    $ 52.78万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了